Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Poly-gamma Glutamic Acid for CIN1
NCT01826045Phase 2Completed
- Sponsor
- MOA Life Plus Co. Ltd.
- Start
- Jun 2013
- Primary completion
- Dec 2015
- Modality
- Peptides, Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of Poly-gamma-glutamic acid in cervical intraepithelial neoplasia (CIN), sponsored by MOA Life Plus Co. Ltd.. Started Jun 2013; status: completed.
02
Drugs
Poly-gamma-glutamic acid
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT01826045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01826045.